Accordingly, reducing the expression of LMP1 with resveratrol might enhance anti-tumor activity in the treatment of LMP1+ EBV-associated B cell malignancies, including Hodgkin’s lymphoma, immunoblastic lymphoma and nasopharyngeal carcinoma. The gene discussed is PDLIM7; the disease is Hodgkins lymphoma.